A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/24 (2006.01) A61K 38/09 (2006.01)
Patent
CA 2196748
Methods useful for treating cancers are disclosed. The methods involve administering human chorionic gonadotropin (hCG) or human luteinizing hormone (hLH) to patients having cancers. Articles of manufacture that are useful for carrying out the described methods are also described. The claimed methods are effective against breast, prostate, ovary, and stomach carcinomas, as well as neuroblastomas, and Kaposi's sarcoma, among others.
L'invention se rapporte à des procédé utilisés dans le traitement des cancers. Ces procédés consistent à administrer de la gonadotrophine chorionique humaine (hCG) ou l'hormone lutéinisante humaine (hLH) à des patients atteints de cancers. L'invention se rapporte également à des produits manufacturés qui sont utiles pour réaliser ces procédés. Les procédés revendiqués sont efficaces contre les cancers du sein, de la prostate, des ovaires et de l'estomac, et également contre les neuroblastomes et la maladie de Kaposi, entre autres.
Bryant Joseph L.
Gallo Robert C.
Lunardi-Iskandar Yanto
Fetherstonhaugh & Co.
Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And
LandOfFree
Treatment of cancer with human chorionic gonadotropin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cancer with human chorionic gonadotropin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cancer with human chorionic gonadotropin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1636714